High expression of QSOX1 is associated with tumor invasiveness and high grades groups in prostate cancer
Authors:
- 1 July 2018
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 214 (7) , 964-967
Abstract
No abstract availableKeywords
Funding Information
- Yeungnam University Research Grant (2017)
This publication has 22 references indexed in Scilit:
- The Emerging Role of QSOX1 in CancerAntioxidants & Redox Signaling, 2014
- An Inhibitory Antibody Blocks the First Step in the Dithiol/Disulfide Relay Mechanism of the Enzyme QSOX1Journal of Molecular Biology, 2013
- A Secreted Disulfide Catalyst Controls Extracellular Matrix Composition and FunctionScience, 2013
- Expression of quiescin sulfhydryl oxidase 1 is associated with a highly invasive phenotype and correlates with a poor prognosis in Luminal B breast cancerBreast Cancer Research, 2013
- Elevated Transcription of the Gene QSOX1 Encoding Quiescin Q6 Sulfhydryl Oxidase 1 in Breast CancerPLOS ONE, 2013
- High expression of QSOX1 reduces tumorogenesis, and is associated with a better outcome for breast cancer patientsBreast Cancer Research, 2012
- Diagnostic and prognostic molecular biomarkers for prostate cancerHistopathology, 2011
- Quiescin Sulfhydryl Oxidase 1 Promotes Invasion of Pancreatic Tumor Cells Mediated by Matrix MetalloproteinasesMolecular Cancer Research, 2011
- Loss of Nkx3.1 leads to the activation of discrete downstream target genes during prostate tumorigenesisOncogene, 2009
- Loss-of-Function of Nkx3.1 Promotes Increased Oxidative Damage in Prostate CarcinogenesisCancer Research, 2005